{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:12:02Z","timestamp":1784632322264,"version":"3.55.0"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["823167"],"award-info":[{"award-number":["823167"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks hormone receptors and HER2 amplification, limiting targeted therapy options. Chemotherapeutics like cisplatin and taxol are commonly used but lack selectivity, often causing harsh side effects. These limitations have led to increased interest in natural health products (NHPs) as complementary treatments due to their potential anticancer benefits and lower toxicity. Black Maitake mushroom (\n                    <jats:italic>Grifola frondosa<\/jats:italic>\n                    ), used in traditional Chinese medicine, contains polysaccharides with reported anticancer activity. However, further research is needed on the whole extract, its mechanism, and its interaction with chemotherapy.\n                  <\/jats:p>\n                  <jats:sec id=\"j_jcim-2025-0255_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      This study assessed the anticancer effects of Black Maitake Odaira Extract\u00a0\u2013 Prothera (BMOE; manufactured by Shogun Maitake Canada, London, ON) on the MDA-MB-231 TNBC cell line. BMOE was evaluated alone and in combination with chemotherapeutic agents cisplatin and taxol using both 2D and 3D\n                      <jats:italic>in\u00a0vitro<\/jats:italic>\n                      models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0255_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Apoptosis was evaluated using Hoechst 33342, Annexin V, and propidium iodide staining. Mitochondrial membrane depolarization was assessed via TMRM. A wound-healing assay measured cell migration. Structural effects were examined in 3D spheroid cultures following treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0255_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BMOE induced dose- and time-dependent apoptosis and mitochondrial depolarization. In 3D models, BMOE disrupted spheroid structure. The wound-healing assay showed impaired TNBC cell migration. Most importantly, BMOE significantly enhanced chemotherapeutic efficacy when combined with cisplatin or taxol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0255_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight the potential of BMOE as a non-toxic adjunct that enhances the efficacy of standard chemotherapies to contribute to the development of safer, more targeted treatment strategies for TNBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2025-0255","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:13:19Z","timestamp":1775776399000},"page":"296-307","source":"Crossref","is-referenced-by-count":0,"title":["Black Maitake mushroom (\n                    <i>Grifola frondosa<\/i>\n                    ) extract exerts anti-cancer effects and enhances the efficacy of chemotherapeutic drugs in 2D and 3D models of triple-negative breast cancer"],"prefix":"10.1515","volume":"23","author":[{"given":"Silvia","family":"DeMarco","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry , 8637 University of Windsor , Windsor , ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Regonda","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry , 8637 University of Windsor , Windsor , ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyaram","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry , 8637 University of Windsor , Windsor , ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026072110581136067_j_jcim-2025-0255_ref_001","doi-asserted-by":"crossref","unstructured":"Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al.. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_002","doi-asserted-by":"crossref","unstructured":"Shaath, H, Elango, R, Alajez, NM. Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer. Cancers 2021;13:5350. https:\/\/doi.org\/10.3390\/cancers13215350.","DOI":"10.3390\/cancers13215350"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_003","doi-asserted-by":"crossref","unstructured":"Cleator, S, Heller, W, Coombes, RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol 2007;8:235\u201344. https:\/\/doi.org\/10.1016\/S1470-2045(07)70074-8.","DOI":"10.1016\/S1470-2045(07)70074-8"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_004","doi-asserted-by":"crossref","unstructured":"Diaz, LK, Sneige, N. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol 2007;14:419\u201330. https:\/\/doi.org\/10.1097\/PAP.0b013e3181594733.","DOI":"10.1097\/PAP.0b013e3181594733"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_005","doi-asserted-by":"crossref","unstructured":"Obidiro, O, Battogtokh, G, Akala, EO. Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics 2023;15:1796. https:\/\/doi.org\/10.3390\/pharmaceutics15071796.","DOI":"10.3390\/pharmaceutics15071796"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_006","doi-asserted-by":"crossref","unstructured":"Dent, R, Trudeau, M, Pritchard, KI, Hanna, WM, Kahn, HK, Sawka, CA, et al.. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-3045.","DOI":"10.1158\/1078-0432.CCR-06-3045"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_007","doi-asserted-by":"crossref","unstructured":"Baranova, A, Krasnoselskyi, M, Starikov, V, Kartashov, S, Zhulkevych, I, Vlasenko, V, et al.. Natural products and the efficacy of chemotherapeutics. J Med Life 2022;15:153\u201361. https:\/\/doi.org\/10.25122\/jml-2021-0108.","DOI":"10.25122\/jml-2021-0108"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_008","doi-asserted-by":"crossref","unstructured":"Aitken, DR, Minton, JP. Complications associated with mastectomy. Surg Clin North Am 2016;63:1331\u201352. https:\/\/doi.org\/10.1016\/S0039-6109(16)43192-0.","DOI":"10.1016\/S0039-6109(16)43192-0"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_009","doi-asserted-by":"crossref","unstructured":"Olsen, MA, Nickel, KB, Fox, IK, Margenthaler, JA, Ball, KE, Mines, D, et al.. Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol 2015;36:907\u201314. https:\/\/doi.org\/10.1017\/ice.2015.108.","DOI":"10.1017\/ice.2015.108"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_010","doi-asserted-by":"crossref","unstructured":"Brown, E, Tirnauer, J. Cell migration and cancer metastasis. Int J Women\u2019s Health 2015;7:567\u201377. https:\/\/doi.org\/10.2147\/IJWH.S55552.","DOI":"10.2147\/IJWH.S55552"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_011","doi-asserted-by":"crossref","unstructured":"Ryan, JL. The future of TNBC therapies. J Invest Dermatol 2012;132:985\u201393. https:\/\/doi.org\/10.1038\/jid.2011.411.","DOI":"10.1038\/jid.2011.411"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_012","doi-asserted-by":"crossref","unstructured":"Jung, Y, Lippard, SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev 2007;107:1387\u2013407. https:\/\/doi.org\/10.1021\/cr068207j.","DOI":"10.1021\/cr068207j"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_013","doi-asserted-by":"crossref","unstructured":"Jordan, MA, Wilson, L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253\u201365. https:\/\/doi.org\/10.1038\/nrc1317.","DOI":"10.1038\/nrc1317"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_014","doi-asserted-by":"crossref","unstructured":"Schiff, PB, Fant, J, Horwitz, SB. Promotion of microtubule assembly in\u00a0vitro by taxol. Nature 1979;277:665\u20137. https:\/\/doi.org\/10.1038\/277665a0.","DOI":"10.1038\/277665a0"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_015","doi-asserted-by":"crossref","unstructured":"Gornstein, E, Schwarz, TL. The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions. Neuropharmacology 2013;76 Pt A:175\u201383. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.016.","DOI":"10.1016\/j.neuropharm.2013.08.016"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_016","doi-asserted-by":"crossref","unstructured":"Clasen, SC, Dinh, PC, Hou, L, Fung, C, Sesso, HD, Travis, LB. Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms. Cardio-Oncology 2021;7. https:\/\/doi.org\/10.1186\/s40959-021-00120-z.","DOI":"10.1186\/s40959-021-00120-z"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_017","doi-asserted-by":"crossref","unstructured":"Ma, Y, Yu, S, Ni, S, Zhang, B, Kung, ACF, Gao, J, et al.. Targeting strategies for enhancing paclitaxel specificity in chemotherapy. Front Cell Dev Biol 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.626910.","DOI":"10.3389\/fcell.2021.626910"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_018","doi-asserted-by":"crossref","unstructured":"Quon, H, Leong, T, Haselow, R, Leipzig, B, Cooper, J, Forastiere, A. Phase III study of radiation therapy with or without cis-platinum in patients with unrespectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382). Int J Radiat Oncol Biol Phys 2011;81:719\u201325. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.038.","DOI":"10.1016\/j.ijrobp.2010.06.038"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_019","doi-asserted-by":"crossref","unstructured":"Walker, FE. Paclitaxel (TAXOL\u00ae): side effects and patient education issues. Semin Oncol Nurs 1993;9:6\u201310. https:\/\/doi.org\/10.1016\/S0749-2081(16)30036-5.","DOI":"10.1016\/S0749-2081(16)30036-5"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_020","doi-asserted-by":"crossref","unstructured":"Warburg, O, Wind, F, Negelein, E. The metabolism of tumors in the body. J Gen Physiol 1927;8:519\u201330. https:\/\/doi.org\/10.1085\/jgp.8.6.519.","DOI":"10.1085\/jgp.8.6.519"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_021","doi-asserted-by":"crossref","unstructured":"Nguyen, C, Pandey, S. Exploiting mitochondrial vulnerabilities to trigger apoptosis selectively in cancer cells. Cancers 2019;11:916. https:\/\/doi.org\/10.3390\/cancers11070916.","DOI":"10.3390\/cancers11070916"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_022","doi-asserted-by":"crossref","unstructured":"Ovadje, P, Ammar, S, Guerrero, JA, Arnason, JT, Pandey, S. Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways. Oncotarget 2016;7:73080\u2013100. https:\/\/doi.org\/10.18632\/oncotarget.11485.","DOI":"10.18632\/oncotarget.11485"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_023","doi-asserted-by":"crossref","unstructured":"Nguyen, C, Baskaran, K, Pupulin, A, Ruvinov, I, Zaitoon, O, Grewal, S, et al.. Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics. BMC Compl Alternative Med 2019;19:98. https:\/\/doi.org\/10.1186\/s12906-019-2505-9.","DOI":"10.1186\/s12906-019-2505-9"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_024","doi-asserted-by":"crossref","unstructured":"He, Y, Zhang, L, Wang, H. The biological activities of the antitumor drug Grifola frondosa polysaccharide. Prog Mol Biol Transl Sci 2019;163:221\u201361. https:\/\/doi.org\/10.1016\/bs.pmbts.2019.02.010.","DOI":"10.1016\/bs.pmbts.2019.02.010"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_025","doi-asserted-by":"crossref","unstructured":"Zhang, J, Liu, D, Wen, C, Liu, J, Xu, X, Liu, G, et al.. New light on Grifola frondosa polysaccharides as biological response modifiers. Trends Food Sci Technol 2022;119:565\u201378. https:\/\/doi.org\/10.1016\/j.tifs.2021.11.017.","DOI":"10.1016\/j.tifs.2021.11.017"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_026","doi-asserted-by":"crossref","unstructured":"Alonso, EN, Ferronato, MJ, Fermento, ME, Gandini, NA, Romero, AL, Guevara, JA, et al.. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells. Oncotarget 2018;9:23396\u2013412. https:\/\/doi.org\/10.18632\/oncotarget.25174.","DOI":"10.18632\/oncotarget.25174"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_027","unstructured":"Shogun Maitake. About maitake. https:\/\/shogunmaitake.com\/about-maitake\/ [Accessed 15 July 2025]."},{"key":"2026072110581136067_j_jcim-2025-0255_ref_028","unstructured":"Corning\u00ae matrigel\u00ae matrix\u00ae. https:\/\/ecatalog.corning.com\/life-sciences\/b2b\/CA\/en\/Surfaces\/Extracellular-Matrices-ECMs\/Corning\u00ae-Matrigel\u00ae-Matrix\/p\/corningMatrigelMatrix [Accessed 15 July 2025]."},{"key":"2026072110581136067_j_jcim-2025-0255_ref_029","doi-asserted-by":"crossref","unstructured":"Ma, D, Pignanelli, C, Tarade, D, Gilbert, T, Noel, M, Mansour, F, et al.. Cancer cell mitochondria targeting by pancratistatin analogs is dependent on functional complex II and III. Sci Rep 2017:42957. https:\/\/doi.org\/10.1038\/srep42957.","DOI":"10.1038\/srep42957"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_030","doi-asserted-by":"crossref","unstructured":"Regonda, S, Iannetta, V, Drew, H, Pandey, S. Black maitake induces apoptosis and enhances the efficacy of standard chemotherapy in 2D and 3D U-87 MG glioblastoma cell models. J Compl Integr Med 2026;23:62\u201370. https:\/\/doi.org\/10.1515\/jcim-2025-0239.","DOI":"10.1515\/jcim-2025-0239"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_031","doi-asserted-by":"crossref","unstructured":"Raad, C, Raad, A, Pandey, S. Green tea leaves and rosemary extracts selectively induce cell death in triple-negative breast cancer cells and cancer stem cells and enhance the efficacy of common chemotherapeutics. Evid Based Complement Alternat Med 2024;2024:9458716. https:\/\/doi.org\/10.1155\/2024\/9458716.","DOI":"10.1155\/2024\/9458716"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_032","doi-asserted-by":"crossref","unstructured":"Crowley, LC, Marfell, BJ, Scott, AP, Waterhouse, NJ. Quantitation of apoptosis and necrosis by Annexin V binding, propidium iodide uptake, and flow cytometry. Cold Spring Harbor Protocols 2016;2016:953\u20137. https:\/\/doi.org\/10.1101\/pdb.prot087288.","DOI":"10.1101\/pdb.prot087288"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_033","doi-asserted-by":"crossref","unstructured":"Rieger, AM, Nelson, KL, Konowalchuk, JD, Barreda, DR. Modified Annexin V\/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp 2011;50:e2597. https:\/\/doi.org\/10.3791\/2597.","DOI":"10.3791\/2597-v"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_034","doi-asserted-by":"crossref","unstructured":"Pollack, A, Ciancio, G. Chapter 3. Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation. Methods Cell Biol 1990;33:19\u201324. https:\/\/doi.org\/10.1016\/S0091-679X(08)60508-7.","DOI":"10.1016\/S0091-679X(08)60508-7"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_035","doi-asserted-by":"crossref","unstructured":"Creed, S, McKenzie, M. Measurement of mitochondrial membrane potential with the fluorescent dye tetramethylrhodamine methyl ester (TMRM). Methods Mol Biol 2019;1928:69-76. https:\/\/doi.org\/10.1007\/978-1-4939-9027-6_5.","DOI":"10.1007\/978-1-4939-9027-6_5"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_036","doi-asserted-by":"crossref","unstructured":"Ovadje, P, Ma, D, Tremblay, P, Roma, A, Steckle, M, Guerrero, JA, et al.. Evaluation of the efficacy & biochemical mechanism of cell death\u00a0induction by Piper longum extract selectively in in-vitro and in-vivo models of human cancer cells. PLoS One 2014;9:e113250. https:\/\/doi.org\/10.1371\/journal.pone.0113250.","DOI":"10.1371\/journal.pone.0113250"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_037","doi-asserted-by":"crossref","unstructured":"Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495\u2013516. https:\/\/doi.org\/10.1080\/0192623070132033.","DOI":"10.1080\/01926230701320337"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_038","doi-asserted-by":"crossref","unstructured":"Liu, J, Enomoto, S, Lancto, CA, Abrahamsen, MS, Rutherford, MS. Inhibition of apoptosis in Cryptosporidium parvum-infected intestinal epithelial cells is dependent on surviving. Infect Immun 2008;76:3784\u201392. https:\/\/doi.org\/10.1128\/iai.00308-08.","DOI":"10.1128\/IAI.00308-08"},{"key":"2026072110581136067_j_jcim-2025-0255_ref_039","doi-asserted-by":"crossref","unstructured":"Marullo, R, Werner, E, Degtyareva, N, Moore, B, Altavilla, G, Ramalingam, SS, et al.. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE 2013;8:e81162. https:\/\/doi.org\/10.1371\/journal.pone.0081162.","DOI":"10.1371\/journal.pone.0081162"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0255\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:59:17Z","timestamp":1784631557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0255\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2026,7,2]]}},"alternative-id":["10.1515\/jcim-2025-0255"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2025-0255","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"value":"2194-6329","type":"print"},{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}